Commit 616cb27e authored by Paul McCarthy's avatar Paul McCarthy 🚵
Browse files

MNT: refresh showcase metadata

parent 8c7adb30
......@@ -233,6 +233,7 @@ encoding_id title availability coded_as structure num_members descript
584 Prefer not to answer 0 11 1 1 Prefer not to answer scalar question
586 Special undetermined dates 0 51 1 3 Used to indicate uncertainty in dates when work given up.
603 COVID-19 antibody study result 0 11 1 3 The results from the self-administered lateral flow devices for detecting COVID-19 antibodies.
605 Dietary food group 0 11 1 94 Groups nutrients by food
609 Mapping of self-reported medical conditions to 3-character ICD10 0 11 1 334 Mapping of self-reported medical conditions to 3-character ICD10
616 Happiness level 0 11 1 12 Happiness level on 10 point scale
620 Distension 0 11 1 12 Levels of distension
......
......@@ -4057,7 +4057,7 @@ field_id title availability stability private value_type base_type item_type str
26226 PRS for enhanced coeliac disease (CED) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26227 PRS for standard coronary artery disease (CAD) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26228 PRS for enhanced coronary artery disease (CAD) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26229 PRS for standard crohn's disease (CD) 0 0 1 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26229 PRS for standard crohn's disease (CD) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26230 PRS for enhanced crohn's disease (CD) 0 0 1 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26231 PRS for enhanced docosahexaenoic acid (DOA) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26232 PRS for standard epithelial ovarian cancer (EOC) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
......@@ -4115,7 +4115,7 @@ field_id title availability stability private value_type base_type item_type str
26284 PRS for enhanced type 1 diabetes (T1D) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26285 PRS for standard type 2 diabetes (T2D) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26286 PRS for enhanced type 2 diabetes (T2D) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26287 PRS for standard ulcerative colitis (UC) 0 0 1 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26287 PRS for standard ulcerative colitis (UC) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26288 PRS for enhanced ulcerative colitis (UC) 0 0 1 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26289 PRS for standard venous thromboembolic disease (VTE) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26290 PRS for enhanced venous thromboembolic disease (VTE) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
......@@ -9062,8 +9062,8 @@ Chapter II Chapter II Neoplasms (140-239) 2 0 N
Chapter III Chapter III Endocrine, nutritional and metabolic diseases, and immunity disorders (240-279) 3 0 N
Chapter IV Chapter IV Diseases of the blood and blood-forming organs (280-289) 4 0 N
Chapter IX Chapter IX Diseases of the digestive system (520-579) 9 0 N
Chapter V Chapter V - Supplementary classification of factors influencing health status and contact with health services 19 0 N
Chapter V Chapter V Mental disorders (230-319) 5 0 N
Chapter V Chapter V - Supplementary classification of factors influencing health status and contact with health services 19 0 N
Chapter VI Chapter VI Diseases of the nervous system and the sense organs (320-389) 6 0 N
Chapter VII Chapter VII Diseases of the circulatory system (390-459) 7 0 N
Chapter VIII Chapter VIII Diseases of the respiratory system (460-519) 8 0 N
......
Supports Markdown
0% or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment